Development of a RNA-Seq Based Prognostic Signature in Lung Adenocarcinoma

Background: Precision therapy for lung cancer will require comprehensive genomic testing to identify actionable targets as well as ascertain disease prognosis. RNA-seq is a robust platform that meets these requirements, but microarray-derived prognostic signatures are not optimal for RNA-seq data. T...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Natl Cancer Inst
Hlavní autoři: Shukla, Sudhanshu, Evans, Joseph R., Malik, Rohit, Feng, Felix Y., Dhanasekaran, Saravana M., Cao, Xuhong, Chen, Guoan, Beer, David G., Jiang, Hui, Chinnaiyan, Arul M.
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2016
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5051943/
https://ncbi.nlm.nih.gov/pubmed/27707839
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djw200
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky